Adipocyte CREB promotes insulin resistance in obesity. 2009

Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Increases in adiposity trigger metabolic and inflammatory changes that interfere with insulin action in peripheral tissues, culminating in beta cell failure and overt diabetes. We found that the cAMP Response Element Binding protein (CREB) is activated in adipose cells under obese conditions, where it promotes insulin resistance by triggering expression of the transcriptional repressor ATF3 and thereby downregulating expression of the adipokine hormone adiponectin as well as the insulin-sensitive glucose transporter 4 (GLUT4). Transgenic mice expressing a dominant-negative CREB transgene in adipocytes displayed increased whole-body insulin sensitivity in the contexts of diet-induced and genetic obesity, and they were protected from the development of hepatic steatosis and adipose tissue inflammation. These results indicate that adipocyte CREB provides an early signal in the progression to type 2 diabetes.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
September 2020, Molecular metabolism,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
March 2024, The Journal of endocrinology,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
December 2021, Nature reviews. Endocrinology,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
January 2018, Adipocyte,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
June 2022, Nature communications,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
May 2008, Cell metabolism,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
October 2021, Communications biology,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
January 2013, Oxidative medicine and cellular longevity,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
February 2015, Cell reports,
Ling Qi, and Maziyar Saberi, and Erik Zmuda, and Yiguo Wang, and Judith Altarejos, and Xinmin Zhang, and Renaud Dentin, and Susie Hedrick, and Gautam Bandyopadhyay, and Tsonwin Hai, and Jerry Olefsky, and Marc Montminy
May 2008, Nature reviews. Molecular cell biology,
Copied contents to your clipboard!